Outset Medical (OM) Common Equity (2019 - 2026)

Outset Medical (OM) has reported Common Equity for 8 consecutive years, with $96.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 37.76% year-over-year to $96.3 million in Q2 2026; TTM through Jun 2026 was $96.3 million, a 37.76% decrease from a year earlier, with the FY2025 full-year figure at $127.0 million, up 373.37% from the prior year.
• Common Equity was $96.3 million for Q2 2026 at Outset Medical, down from $111.7 million in the prior quarter.
• Over five years, Common Equity peaked at $345.5 million in Q1 2022 and troughed at $26.8 million in Q4 2024.
• A 5-year average of $160.7 million and a median of $147.2 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity tumbled 78.18% in 2024 and soared 373.37% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $246.0 million in 2022, then tumbled by 50.04% to $122.9 million in 2023, then plunged by 78.18% to $26.8 million in 2024, then soared by 373.37% to $127.0 million in 2025, then retreated by 24.12% to $96.3 million in 2026.
• The last three Common Equity figures came in at $96.3 million (Q2 2026), $111.7 million (Q1 2026), and $127.0 million (Q4 2025), per Business Quant data.